Diagnostic Testing Patterns and Concordance with World Health Organization (WHO) Criteria for Patients (Pts) with Newly Diagnosed (ND) Myelodysplastic Syndromes (MDS) in the Connect® MDS/AML Registry
Year: 2019
Type: conference-abstract
Source: Blood
Institutions: University of Utah, ARUP Laboratories (United States), University of Florida, The University of Texas MD Anderson Cancer Center, Endeavor Health, Moffitt Cancer Center, Vanderbilt University Medical Center, Fred Hutch Cancer Center, Cleveland Clinic, Dana-Farber Cancer Institute, Celgene (United States), University of New Mexico Health Sciences Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2988895627
